Silencing of the Mutant Huntingtin Gene Through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an in Vitro Model of Huntington’s Disease

Cell Transplantation - United States
doi 10.1177/0963689719840662
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Inhibition of Aggregation of Mutant Huntingtin by Nucleic Acid Aptamers in Vitro and in a Yeast Model of Huntington’s Disease

2018English

Genistein Induces Degradation of Mutant Huntingtin in Fibroblasts From Huntington’s Disease Patients

Metabolic Brain Disease
BiochemistryMolecular NeuroscienceNeurologyCellular
2019English

PIAS1 Regulates Mutant Huntingtin Accumulation and Huntington’s Disease-Associated Phenotypes in Vivo

Neuron
Neuroscience
2016English

In Vitro CRISPR/Cas9-Directed Gene Editing to Model LRRK2 G2019S Parkinson’s Disease in Common Marmosets

Scientific Reports
Multidisciplinary
2020English

Huntington’s Disease: From the Physiological Function of Huntingtin to the Disease

2012English

Huntingtin Lowering Strategies for Disease Modification in Huntington’s Disease

Neuron
Neuroscience
2019English

An in Vitro Perspective on the Molecular Mechanisms Underlying Mutant Huntingtin Protein Toxicity

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2012English

130. Gene Editing of the AAVS1 Locus With CRISPR/Cas9

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Targeting N-Terminal Huntingtin With a Dual-sgRNA Strategy by CRISPR/Cas9

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy